Skip to main content

Rex Colle Bentley

Professor of Pathology
Pathology
Duke Box 3712, Durham, NC 27710
216A Davison Bldg, Durham, NC

Overview


Outcome-based research on pathology of endometrial carcinoma, including prognostic significance of histologic features of endometrial carcinoma, variants of endometrial carcinoma, definitions of atypia and well-differentiated carcinoma, and collaborative studies of oncogenes and tumor suppressor genes in endometrial carcinoma.

Endometrial pathology, especially as it relates to molecular/genetic alterations in neoplasms.

Ovarian pathology, especially as it relates to molecular and genetic alterations in neoplasms.

Improving accuracy of radiographic screening for breast cancer, by careful patho-radiographic correlation and study of improved imaging techniques (especially ultrasound).

Use of electron microscopy as a diagnostic and research technique.

Objective measures of pathology resident performance.

Current Appointments & Affiliations


Professor of Pathology · 2012 - Present Pathology, Clinical Science Departments
Member of the Duke Cancer Institute · 1986 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


Supplementary Table from Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States

Other · November 26, 2025 Supplementary Table from Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States ... Full text Cite

Supplementary Table from Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States

Other · November 26, 2025 Supplementary Table from Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States ... Full text Cite
View All Publications

Recent Grants


Validation of UM1 candidate targets in fusion-positive rhabdomyosarcoma preclinical models

ResearchCollaborator · Awarded by Massachusetts Institute of Technology · 2024 - 2029

ZEB2 as a cell fate switch in fusion-positive rhabdomyosarcoma

ResearchCollaborator · Awarded by Hyundai Hope on Wheels · 2024 - 2026

View All Grants

Education, Training & Certifications


Harvard University · 1986 M.D.